In this study, we discovered that that knockdown of Chemerin only partially inhibited JAK2 or STAT3 phosphorylation, indicating that Chemerin partially contributed to the tumor-promoting effect of neutrophils on OSCC cells. The gene discussed is JAK2; the disease is neoplasm.